Kambo is not a psychedelic. It contains no compounds that act on the serotonin receptors responsible for the hallucinations and altered perception caused by classic psychedelics like psilocybin, LSD, or DMT. Kambo is the dried skin secretion of the giant monkey frog (Phyllomedusa bicolor), and its active ingredients are bioactive peptides that trigger an intense physical purge rather than a mental trip. The confusion likely stems from kambo’s association with Amazonian shamanic traditions and its frequent pairing with ayahuasca retreats, but pharmacologically, the two substances have almost nothing in common.
What Kambo Actually Contains
The secretion is a cocktail of short-chain peptides, each with a different target in the body. The most abundant is phyllocaerulein, which mimics a gut hormone called cholecystokinin. It stimulates the adrenal cortex and pituitary gland, drops blood pressure, and is largely responsible for the intense nausea, vomiting, and urge to defecate that define a kambo session. Phyllomedusin, another key peptide, causes smooth muscle contraction throughout the gut and further lowers blood pressure while triggering the release of antidiuretic hormones.
The peptides that come closest to being “mind-altering” are dermorphins and deltorphins. These bind powerfully to opioid receptors, the same receptors targeted by morphine. Dermorphins activate the mu-opioid receptor, producing analgesia, euphoria, and a trance-like state sometimes described as catatonia. Deltorphins are highly selective for the delta-opioid receptor, with binding strength measured at fractions of a nanomole. These opioid effects explain the post-purge feelings of calm, pain relief, and heightened alertness that users describe. But opioid activity is fundamentally different from psychedelic activity. There are no tryptamines, no phenethylamines, and no known interaction with the serotonin 2A receptor pathway that defines classic psychedelics.
Why People Confuse It With Psychedelics
Kambo often appears on the same retreat menus as ayahuasca and is administered in ceremonial settings by practitioners who use the language of shamanism. Its origins are indigenous Amazonian, and it’s sometimes grouped under the umbrella of “plant medicine,” even though it comes from a frog and works through entirely different mechanisms. One early ethnographic report suggested that vivid hallucinations occur during kambo use, but subsequent research has not supported this as a typical experience. In one clinical case report, a woman developed visual and auditory hallucinations after a kambo session, but this occurred alongside seizures and loss of consciousness, pointing to a neurological crisis rather than a psychedelic effect.
Kambo is also sometimes confused with the secretion of the Sonoran Desert toad (Bufo alvarius), which genuinely does contain the psychedelic tryptamines 5-MeO-DMT and bufotenin. These are completely different species with completely different chemistry.
What the Experience Actually Feels Like
A kambo session begins with the practitioner creating small, superficial burns on the skin, typically on the upper arm, leg, or chest, using a smoldering stick or incense. Dried kambo secretion is mixed with water to form a paste and applied directly to these open points, allowing the peptides to enter the lymphatic system. Participants usually drink a large volume of water beforehand.
Within minutes, the effects hit. Blood pressure drops sharply, the heart races to compensate, and the face often swells. Violent vomiting and diarrhea follow, sometimes accompanied by heavy sweating and salivation. The acute phase typically lasts 20 to 40 minutes. Afterward, users commonly report a period of calm, mental clarity, sharpened senses, and reduced sensitivity to pain and hunger. These aftereffects align with the opioid peptides in the secretion rather than any psychedelic mechanism.
The experience is overwhelmingly physical. There are no geometric visuals, no ego dissolution, no sense of expanded consciousness in the way psychedelic users describe those states. The central effects that follow the purge, including feelings of increased physical strength and resistance to fatigue, are what originally made kambo valuable to indigenous hunters.
Traditional Use vs. Modern Practice
Among indigenous groups like the Matsés of the Amazon basin, kambo was a hunting tool. Warriors applied it before hunts to sharpen their senses, reduce hunger and thirst, and increase physical endurance. The ritual was meant to cleanse “panema,” a concept roughly translating to bad luck in hunting.
As kambo spread to Western urban centers, its framing shifted. The definition of panema broadened to something closer to “negative energy” or depression, and kambo was repackaged as a neo-shamanic healing ritual. Researchers have described this transformation as the “shamanization of kambo,” a process that wrapped a physiological purgative in spiritual language and positioned it alongside genuinely psychoactive substances like ayahuasca. This cultural rebranding is a major reason people assume kambo is psychedelic when it is not.
Serious Physical Risks
Because kambo’s effects are primarily cardiovascular and gastrointestinal, the dangers are physical rather than psychological. The combination of profuse vomiting, diarrhea, and the ritual practice of drinking large amounts of water can cause dangerous drops in blood sodium levels, a condition called hyponatremia. In one documented case, a patient’s sodium fell to 123 mmol/L (normal is 135 to 145), with simultaneous drops in potassium and chloride. The resulting fluid shifts caused brain swelling and ultimately brain death.
The peptides in kambo also cause significant swings in blood pressure and heart rate. This makes it particularly dangerous for people with heart conditions, a history of stroke, blood clots, aneurysms, or naturally low blood pressure. Other high-risk groups include people with epilepsy (kambo has triggered seizures), those on immunosuppressive therapy or recovering from surgery, and pregnant women, as the intense abdominal contractions can interfere with pregnancy. The U.S. State Department specifically warns travelers against using kambo, noting that American citizens have suffered serious illness and death after exposure.
Unlike psychedelics, where the primary acute risks tend to be psychological, kambo’s risks are organ-level: electrolyte collapse, cardiovascular stress, and in rare cases, organ failure. There is no regulated dosing, no standardized preparation, and the peptide concentration varies from frog to frog and batch to batch.
Legal Status
Kambo occupies an unusual legal gray area. Because it contains no scheduled psychoactive compounds, it is not classified as a controlled substance in most countries, including the United States. It is not illegal to possess or administer in most jurisdictions, though it is also not approved as a medicine by any regulatory body. Brazil, where kambo originates, has restricted advertising it as a therapeutic treatment. Australia has moved toward tighter regulation. The lack of formal legal status means there is also no oversight of practitioners, dosing, or safety protocols.

